Please use this identifier to cite or link to this item: http://ir.swu.ac.th/jspui/handle/123456789/13715
Title: A randomized double-blind controlled trial of Lactobacillus acidophilus plus bifidobacterium bifidum versus placebo in patients with hypercholesterolemia
Authors: Rerksuppaphol S.
Rerksuppaphol L.
Keywords: cholesterol
high density lipoprotein cholesterol
low density lipoprotein cholesterol
placebo
probiotic agent
triacylglycerol
adult
Article
Bifidobacterium bifidum
cholesterol blood level
clinical article
controlled study
double blind procedure
female
human
hypercholesterolemia
Lactobacillus acidophilus
loose feces
male
middle aged
nonhuman
obesity
randomized controlled trial
systolic blood pressure
Bifidobacterium bifidum
Lactobacillus acidophilus
Issue Date: 2015
Abstract: Background: Hypercholesterolemia is a major risk factor for cardiovascular disease. Not all patients respond well to traditional cholesterol lowering medications. Probiotics have been evaluated for their cholesterol-lowering effects in humans with variable results. This study was performed to evaluate the efficacy of two probiotics in lowering the serum cholesterol of hypercholesterolemic patients. Materials and Methods: A randomized double-blind controlled trial was conducted comparing placebo to Lactobacillus acidophilus plus Bifidobacterium bifidum in patients diagnosed with hypercholesterolemia. Placebo or probiotic capsules were taken three times daily for six weeks. Pre- and post-treatment total cholesterol (TC), HDL-cholesterol (HDL-C), LDL-cholesterol (LDL-C) and triglyceride (TG) levels and demographic parameters of the two groups were compared. From a total of 70 participants, 64 completed the assigned treatment (31 in probiotics group and 33 in the control group).The two treatment groups were matched for age, sex, weight, height, BMI, waist and hip circumferences, and blood pressure. Results: Baseline evaluation revealed no difference between the probiotics group and control group levels of TC, HDL-C, LDL-C and TG. TC levels in the probiotics group decreased during treatment (237.2 vs. 212.7 mg/dL, p<0.05). TC and LDL-C levels in the control group increased significantly from their baseline levels during treatment. TC (212.7 vs 252.8 mg/dL, p<0.001), HDL-C (52.0 vs 59.1 mg/dL, p=0.04) and LDL-C (153.9 vs 182.1 mg/dL, p<0.01) levels in the probiotics group were significantly lower at the end of treatment than the corresponding levels in the control group. Conclusion: A combination of Lactobacillus acidophilus and Bifidobacterium bifidum decreased serum total cholesterol, LDL-cholesterol and HDL-cholesterol levels in hypercholesterolemic patients over a six week period. There was no effect on serum triglyceride or fasting blood glucose levels. © 2015, Journal of Clinical and Diagnostic Research. All Rights Reserved.
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84924692200&doi=10.7860%2fJCDR%2f2015%2f11867.5728&partnerID=40&md5=e4ab00df80066ba2c7f8f32d5bfd0266
http://ir.swu.ac.th/jspui/handle/123456789/13715
ISSN: 2249782X
Appears in Collections:SCOPUS 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.